Dr. Luke Robert Salbert, MD

Dr. Salbert practices at Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health.

Dr. Salbert's NPI, 1194383380, was assigned on June 3, 2019. Dr. Salbert holds Michigan license 4301508839.

Dr. Salbert's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth, at 100 Michigan St NE, Grand Rapids, MI 49503 in Kent County. The practice phone is (616) 391-1774.

Dr. Salbert's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health. Dr. Salbert is also affiliated with Corewell Health Lakeland Hospitals - Saint Joseph Hospital. The medical group on file is Corewell Health Medical Group West. Dmand AI also links Dr. Salbert to 2 more hospitals, 5 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salbert practices, 7 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Salbert's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Salbert is licensed in Michigan.

CMS data shows 65 Medicare services from Dr. Salbert across 2 procedure codes in 2024, for 53 Medicare patients. Medicare paid $7,791 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 53 Medicare patients who saw Dr. Salbert in 2024. The largest group is 65 to 74, with 21 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Salbert's median patient age at 57, with 50% women.

In 2024, Dr. Salbert wrote 233 Medicare Part D claims for 53 patients. 70% of them were for generic drugs. CMS names the drug for 161 of them, across 7 drugs with 11 or more claims each, at $66,899 in total drug cost. In 2023, CMS named 79 claims across 2 drugs.

Dr. Salbert accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Salbert as offering telehealth.

Dmand AI links 1 paper to Dr. Salbert in 2021. Dr. Salbert's most frequent co-authors are Nathan A. Lambert-Cheatham, DO, Lina Nagia, DO and Jayne Heather Ward, DO.

CMS Open Payments shows 23 general payments to Dr. Salbert from 10 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. UCB, Inc. paid the most, $431.